Literature DB >> 26179249

Evidence for a genetical contribution to non-smoking-related lung cancer.

Shamus R Carr1, Wallace Akerley2, Mia Hashibe3, Lisa A Cannon-Albright4.   

Abstract

BACKGROUND: The majority of lung cancers are smoking-related, with environmental and genetical factors contributing. The interplay between environmental and genetical contributions in non-smoking-related lung cancers is less clear.
METHODS: We analysed a population-based computerised genealogy resource linked to a state-wide cancer registry of lung cancer cases (n=5544) for evidence of a genetical contribution to lung cancer predisposition in smoking (n=1747) and non-smoking cases (n=784). Statistical methods were used to test for significant excess relatedness of cases and estimate relative risk (RR) in close and distant relatives of lung cancer cases.
RESULTS: Significant excess relatedness was observed for all lung cancer cases (p<0.001) and for the subsets of smoking-related (p<0.001) and non-smoking-related (p<0.001) cases when all pairwise relationships were considered. Only the non-smoking-related subset of cases showed significant excess relatedness when close relationships were ignored (p=0.020). First-degree, second-degree, and fourth-degree relatives of non-smoking-related lung cancer cases had significantly elevated RR. An even higher elevated RR was observed for first-degree, second-degree, third-degree and fourth-degree relatives of smoking-related lung cancer cases.
CONCLUSIONS: Non-smoking-related lung cancer cases show significant excess relatedness for close and distant relationships, providing strong evidence for a genetical contribution as well as an environmental contribution. Significant excess relatedness for only close family relationships in all lung cancer cases and in only smoking-related lung cancer cases implies environmental contribution. Additionally, the highest RR for lung cancer was observed in the relatives of smoking-related lung cancer, suggesting predisposition gene carriers who smoke are at highest risk for lung cancer. Screening and gene identification should focus on high-risk pedigrees. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Clinical Epidemiology; Lung Cancer

Mesh:

Year:  2015        PMID: 26179249     DOI: 10.1136/thoraxjnl-2014-206584

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  5 in total

1.  Population-Based Relative Risks for Lung Cancer Based on Complete Family History of Lung Cancer.

Authors:  Lisa A Cannon-Albright; Shamus R Carr; Wallace Akerley
Journal:  J Thorac Oncol       Date:  2019-05-07       Impact factor: 15.609

Review 2.  Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine.

Authors:  Michele Carbone; Ivano Amelio; El Bachir Affar; James Brugarolas; Lisa A Cannon-Albright; Lewis C Cantley; Webster K Cavenee; Zhijian Chen; Carlo M Croce; Alan D' Andrea; David Gandara; Carlotta Giorgi; Wei Jia; Qing Lan; Tak Wah Mak; James L Manley; Katsuhiko Mikoshiba; Jose N Onuchic; Harvey I Pass; Paolo Pinton; Carol Prives; Nathaniel Rothman; Said M Sebti; James Turkson; Xifeng Wu; Haining Yang; Herbert Yu; Gerry Melino
Journal:  Cell Death Differ       Date:  2018-10-15       Impact factor: 15.828

3.  Genetic variants in lncRNA HOTAIR are associated with lung cancer susceptibility in a Chinese Han population in China: a case-control study.

Authors:  Hang Li; Zitai Yang; Juan Li; Xiaoting Lv; Min Gao; Yanhong Bi; Ziwei Zhang; Shengli Wang; Sixuan Li; Na Li; Zhigang Cui; Baosen Zhou; Zhihua Yin
Journal:  Cancer Manag Res       Date:  2018-10-31       Impact factor: 3.989

4.  Clinical Characteristics and Molecular Profiles of Lung Cancer in Ethiopia.

Authors:  Tewodros H Gebremariam; Deborah A Haisch; Helen Fernandes; Dawit K Huluka; Amsalu B Binegdie; Mathewos A Woldegeorgis; Wondwosen Ergetie; Aschalew Worku; Lillian M Zerihun; Matthew Cohen; Pierre P Massion; Charles B Sherman; Anjali Saqi; Neil W Schluger
Journal:  JTO Clin Res Rep       Date:  2021-05-31

5.  Using a genetic/clinical risk score to stop smoking (GeTSS): randomised controlled trial.

Authors:  John A A Nichols; Paul Grob; Wendy Kite; Peter Williams; Simon de Lusignan
Journal:  BMC Res Notes       Date:  2017-10-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.